Gironacci M M, Adler-Graschinsky E, Peña C, Enero M A
Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
Hypertension. 1994 Oct;24(4):457-60. doi: 10.1161/01.hyp.24.4.457.
We examined the effects of angiotensin II (Ang II) and Ang-(1-7) on the release of [3H]norepinephrine elicited by nerve stimulation (2 Hz, 0.5 millisecond, for 2 minutes) in rat atria isolated with their cardioaccelerans nerves. The stimulation-induced release of [3H]norepinephrine was increased 50% by 3 x 10(-8) mol/L of either peptide. No further increase in [3H]norepinephrine release was observed with peptide concentrations up to 3 x 10(-7) mol/L. This effect was completely blocked by the nonselective angiotensin receptor antagonist saralasin (1 x 10(-7) mol/L). The type 1 angiotensin receptor antagonist DuP 753 (1 x 10(-6) mol/L) entirely prevented the increases in [3H]norepinephrine caused by Ang II and Ang-(1-7). On the other hand, the type 2 angiotensin receptor antagonist PD 123319 (1 x 10(-6) mol/L) prevented the increase in [3H]norepinephrine release elicited by Ang-(1-7) but not by Ang II. These results suggest that Ang-(1-7), like Ang II, could have a neuromodulatory function in rat atria via activation of specific angiotensin receptor subtypes, which could be the subtype 1 angiotensin receptor for Ang II and subtypes 1 and 2 for Ang-(1-7).
我们研究了血管紧张素II(Ang II)和血管紧张素-(1-7)(Ang-(1-7))对分离出心加速神经的大鼠心房中,由神经刺激(2赫兹,0.5毫秒,持续2分钟)引发的[3H]去甲肾上腺素释放的影响。两种肽类物质,浓度为3×10^(-8)摩尔/升时,刺激诱导的[3H]去甲肾上腺素释放增加了50%。肽浓度高达3×10^(-7)摩尔/升时,未观察到[3H]去甲肾上腺素释放进一步增加。非选择性血管紧张素受体拮抗剂沙拉新(1×10^(-7)摩尔/升)完全阻断了这一效应。1型血管紧张素受体拮抗剂杜普753(1×10^(-6)摩尔/升)完全阻止了由Ang II和Ang-(1-7)引起的[3H]去甲肾上腺素增加。另一方面,2型血管紧张素受体拮抗剂PD 123319(1×10^(-6)摩尔/升)阻止了由Ang-(1-7)而非Ang II引起的[3H]去甲肾上腺素释放增加。这些结果表明,与Ang II一样,Ang-(1-7)可能通过激活特定的血管紧张素受体亚型,在大鼠心房中具有神经调节功能,对于Ang II可能是1型血管紧张素受体,对于Ang-(1-7)则是1型和2型血管紧张素受体。